Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
BrainStorm Cell Therapeutics Inc. is a biotechnology company specializing in autologous cellular therapies for neurodegenerative diseases such as ALS, progressive multiple sclerosis, and Alzheimer’s. Its proprietary NurOwn® platform uses patients’ own bone marrow-derived mesenchymal stem cells induced to secrete neurotrophic factors, aiming to modulate neuroinflammation, promote neuronal survival, and improve neurological function. The company focuses on clinical development, manufacturing, and commercialization of these cell therapies primarily in the U.S. and Europe.
This description was generated via AI from an annual report. Updated about 1 year ago.